Published • loading... • Updated
AbbVie (NYSE:ABBV) Price Target Raised to $346.00
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AbbVie (NYSE:ABBV) Price Target Raised to $346.00
AbbVie (NYSE:ABBV – Free Report) had its target price upped by Morgan Stanley from $310.00 to $346.00 in a report released on Monday morning,Benzinga reports. The firm currently has an overweight rating on the stock. A number of other equities analysts have also commented on ABBV. Leerink Partners boosted their price target on shares of […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
